• Info
  • Insider Ownership

Insider Trading & Ownership of Carrie L. Bourdow

Location
King Of Prussia, PA
Summary
The estimated net worth of Carrie L. Bourdow is at least $73,504 dollars as of 10 Oct 2024. Carrie L. Bourdow is the Acting CEO, Director of TREVENA INC and owns shares of TREVENA INC stock worth about $35.1K. Carrie L. Bourdow is the Director of Sesen Bio, Inc. and owns shares of Carisma Therapeutics Inc. (CARM) stock worth about $23.5K. Carrie L. Bourdow is the Director of Nabriva Therapeutics plc and owns shares of Nabriva Therapeutics plc stock worth about $14.9K.
Signature
/s/ Jennifer Keyser, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Carrie L. Bourdow and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Carrie L. Bourdow has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $73,504.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: TREVENA INC ($35,124).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Carrie L. Bourdow

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRVN TREVENA INC Acting CEO, Director $35,124 08 Oct 2024
CARM Sesen Bio, Inc. Director $23,480 22 Jun 2022
NBRV Nabriva Therapeutics plc Director $14,900 01 Aug 2022

Insider Transactions Reported by Carrie L. Bourdow:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.